CarD-T: an automated pipeline for the nomination and analysis of potential human carcinogens
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgaf074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Jamey O'Neill und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mechanical Engineering Department, San Diego State University, San Diego, CA 92182, United States. Hauptthemen laut MEDLINE: Carcinogens, Machine Learning, Neoplasms. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS, NIH, NCI NIH HHS.
Abstract (Originalsprache)
The identification and classification of carcinogens is critical in cancer epidemiology, necessitating updated methodologies to manage the burgeoning biomedical literature. We introduce the Carcinogen Detection via Transformers (CarD-T) framework, combining transformer-based machine learning with probabilistic analysis to efficiently nominate potential carcinogens from scientific texts. Trained on 60% of established carcinogens, CarD-T correctly identifies all remaining known carcinogens and nominates ∼1600 potential new carcinogens. Comparative assessment against GPT-4 reveals CarD-T's comparable precision (0.896 versus 0.903), and superior recall (0.853 versus 0.757), implying an improved ability to nominate potential carcinogens for further evaluation. CarD-T associates each nominated entity with relevant scientific literature, allowing for additional analysis of conflicting implications over time through a Bayesian probabilistic carcinogen denomination analysis. The framework also provides rich insights into carcinogenesis associated research, revealing significant shifts in research focus on carcinogenic agents over time, from chemical carcinogens to broader categories including biological agents, environmental factors and lifestyle choices. We establish the CarD-T framework as a locally deployable, computationally inexpensive, and robust tool for identifying and nominating potential carcinogens from vast biomedical literature. This framework enhances the agility of public health responses to carcinogen identification, setting a new benchmark for automated, scalable toxicological investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mechanical Engineering Department, San Diego State University, San Diego, CA 92182, United States.
- Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, United States.
- Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA 92093, United States.
- Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, United States.
- Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, United States.
- Sanford Stem Cell Institute, University of California San Diego, La Jolla, CA 92093, United States.
ORCID-Profile: Jamey O'Neill, Ludmil Alexandrov, Parag Katira
Förderung
- NIMHD NIH HHS
- NIH
- NCI NIH HHS
- NIMHD
- NCI
Zitieren
APA
O'Neill, J., Reddy, G. A., Dhillon, N., Tripathi, O., Alexandrov, L., & Katira, P. (2025). CarD-T: an automated pipeline for the nomination and analysis of potential human carcinogens. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf074
Vancouver
O'Neill J, Reddy GA, Dhillon N, Tripathi O, Alexandrov L, Katira P. CarD-T: an automated pipeline for the nomination and analysis of potential human carcinogens. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf074
BibTeX
@article{ONeill2025,
author = {O'Neill, Jamey and Reddy, Gudur Ashrith and Dhillon, Nermeeta and Tripathi, Osika and Alexandrov, Ludmil and Katira, Parag},
title = {CarD-T: an automated pipeline for the nomination and analysis of potential human carcinogens},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgaf074}
}
EUVIMED